YOLFTbeta
Zenicor Medical Systems AB

Zenicor Medical Systems AB

ZENI · ST · Healthcare / Medical Devices

0.79SEK+0.06 (+8.22%)

Price History

Full chart

Market Stats

Previous Close0.73
Open0.73
Day Range0.73 – 0.79
52-Week Range0.805 – 1.59
Volume4.21K
Market Cap23.59M
P/E (TTM)45.00
Forward P/E0.00
EPS0.02
Dividend Yield0.00%
Beta0.86
50-Day Avg0.9484
200-Day Avg1.08

About

Zenicor Medical Systems AB (publ), a medical technology company, develops systems and care chains for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor One, a handheld ECG device for arrhythmia; Zenicor Flex, a device that provides ECG data and arrhythmia detection; and Zenicor View, a web-based system solution for all types of arrhythmia investigations. It also provides Zenicor Direct, a solution with interpretation services and services for device logistics; and DeepRhythmAI, an AI technology of Zenicor Solution for modern arrhythmia diagnostics. The company was incorporated in 2003 and is headquartered in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Mats Palerius
  • Employees20
  • HeadquartersSaltmätargatan 8, Stockholm, Sweden, 113 59, Sweden
  • Websitehttps://zenicor.se

Leadership

  • Mr. Mats PaleriusCo-Founder, CEO & Director · b. 1960
  • Liz MuwangaSustainability Manager and Quality & Regulatory Affairs Specialist

Financials

Income Statement

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-17.94M19.66M21.48M24.16M25.21M27.92M
Growth (%)--+9.57%+9.27%+12.46%+4.37%+10.76%
Cost of Revenue--1.08M-1.15M-2.80M-4.15M-2.84M528.00K
Gross Profit-19.02M20.81M24.28M28.31M28.05M27.40M
Gross Margin-105.99%105.85%113.04%117.19%111.27%98.11%
Operating Expense-17.23M19.59M25.05M32.42M27.93M25.28M
Operating Income-1.79M1.21M-765.30K-4.11M126.05K2.11M
Operating Margin-9.96%6.17%-3.56%-17.02%0.50%7.57%
EBITDA---92.90K-852.41K4.46M6.65M
EBITDA Margin---0.43%-3.53%17.69%23.82%
Net Income-1.43M628.82K-1.75M-5.59M-2.08M214.49K
Net Income Margin-7.95%3.20%-8.13%-23.13%-8.27%0.77%
Interest Expense-435.29K632.15K1.11M1.64M2.31M2.20M
Interest Expense % of Total Revenue-2.43%3.22%5.18%6.78%9.15%7.88%

Balance Sheet

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-32.97M40.43M45.92M60.22M63.23M77.73M
Total Liabilities-15.56M22.38M29.62M29.65M34.75M20.78M
Total Equity-17.42M18.05M16.30M30.57M28.48M56.94M
Cash-1.19M1.07M589.23K3.12M911.70K5.11M
Net Debt-6.56M10.52M17.25M12.87M18.76M7.22M

Cash Flow

Currency: SEK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--2.89M2.49M5.87M-7.04M-596.23K-9.74M
Capital Expenditure005.33M6.34M12.45M8.22M6.96M5.30M
Free Cash Flow---2.44M-3.85M-6.58M-15.26M-7.56M-15.05M
FCF to OCF---84.32%-154.25%-112.14%216.74%1267.88%154.43%

Earnings

Report DateDec 31, 2014Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Feb 16, 2018May 18, 2018Aug 17, 2018Nov 16, 2018Feb 15, 2019May 17, 2019Aug 23, 2019Nov 15, 2019Feb 14, 2020May 15, 2020Aug 21, 2020Nov 13, 2020Feb 12, 2021May 7, 2021Sep 1, 2021Dec 1, 2021Feb 11, 2022May 6, 2022Aug 26, 2022Nov 18, 2022Feb 10, 2023May 31, 2023Sep 1, 2023Nov 17, 2023Feb 16, 2024Apr 26, 2024Aug 2, 2024Oct 25, 2024Feb 17, 2025May 30, 2025Aug 29, 2025Nov 28, 2025Feb 16, 2026Apr 30, 2026Jul 31, 2026
EPS Estimate----------0.18--0.200.040.150.21-0.16-0.01-0.290.090.09----------------------
EPS Actual-0.23-0.24-0.04-0.10-0.250.020.02-0.21-0.24-0.070.01-0.32-0.05-0.070.040.01-0.250.160.090.030.010.070.010.010.020.020.01-0.14-0.16-0.07-0.10-0.34-0.13-0.17-0.05-0.070.07-0.05-0.01-0.030.050.010.00
Surprise---------61.11%--60.00%-225.00%-146.67%-80.95%106.25%-2400.00%--68.97%-66.67%-88.89%----------------------
Timing--------After-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market---------------------

Key Statistics & Ratios

Market Cap23.59M
Enterprise Value34.01M
Trailing P/E45.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.81
Price / Book0.41
EPS0.02
Book Value2.17
Revenue (TTM)28.97M
Gross Profit (TTM)24.23M
EBITDA4.15M
Profit Margin3.51%
Operating Margin6.76%
Return on Equity2.10%
Return on Assets2.53%
Shares Outstanding26.21M
Shares Float21.91M
Beta0.86
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%